Search

Breast augmentation from a patient perspective

When I was 17 and saw Pamela Anderson on Baywatch I knew I wanted to have breast implants. A plastic surgeon had an office nearby so I went to find out more. The woman who spoke with me was lovely,...

IN RESPONSE TO: Plastic surgery and aesthetic medicine - specialties and specialists

I read with great interest the article ‘Plastic surgery and aesthetic medicine: specialties and specialists’ by Professor Andrew Burd published in the Feb/Mar issue of PMFA News. Prof Burd brings up many valid points about the specialty of plastic surgery...

Botulinum toxin (BoNT) for depression: A review of the mechanism of action and its potential place as an adjuvant treatment

BoNT is becoming a recognised efficient treatment for depression, endorsed by several disciplines including psychiatry. Clare Amrani examines the potential mechanism of action and explores the appropriate place of BoNT in the therapeutic armamentarium for depression. How did BoNT become...

The REAL Clinic: the sustainable building and running of a new clinic

Naveen Cavale is CEO and Consultant Plastic Surgeon at the REAL Clinic, a small clinic near the Battersea Power Station, South London. He has offered The PMFA Journal his insights into the setting up, and running, of a new hospital....

Informed consent and failure to disclose – legal perspectives for aesthetic surgeons

As litigation and legal claims in aesthetic surgery and medicine continue to rise, informed consent is not only a legal imperative but also essential in protecting yourself and your business. Lee Seng Khoo and Francesco Mazzarone, from the world-renowned Ivo...

Chin augmentation: filler versus prosthesis

Over recent years, aesthetic medicine and aesthetic surgery have become closer and more combined in daily practice. There is also a gradual shift, with aesthetic doctors performing more invasive techniques, whereas plastic surgeons are also, whenever possible, moving to less...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...